Deep Genomics
ProfileJobs

Deep Genomics

Suggest Edit
    • HealthTechnologyartificial intelligencehealthtechmachine learning

    Deep Genomics develops a machine learning technology to understand how genetic variations lead to diseases. It develops an integrated computational system that could learn, predict and interpret how genetic variation, whether natural or therapeutic, alters crucial cellular processes. The Company offers SPIDEX database, which is a set of genetic variants and their predicted effects on human splicing across the entire genome.

    Total Funding
    $3.7 M
    Type
    Private
    HQ
    Toronto, CA
    Founded
    2014
    Size (employees)
    26 (est)+14%
    Website
    deepgenomics.com
    Deep Genomics was founded in 2014 and is headquartered in Toronto, CA
    Report incorrect company information

    Deep Genomics Office Locations

    Deep Genomics has an office in Toronto
    Toronto, CA (HQ)
    MaRS Centre, Heritage Building, Suite 320
    Show all (1)
    Report incorrect company information

    Deep Genomics Financials and Metrics

    Summary Metrics

    Founding Date

    		2014

    Total Funding

    		$3.7 m

    Latest funding size

    		$3.70 m

    Time since last funding

    		2 years ago

    Investors

    		True Ventures, Bloomberg Beta, Eleven Two Capital
    Deep Genomics's latest funding round in November 2015 was reported to be $3.7 m. In total, Deep Genomics has raised $3.7 m
    Report incorrect company information

    Competitors

    Acerta
    Automotive - Private
    Spring Care
    Health - Private
    Human Dx
    Health - Private
    BenevolentAI
    Health - Private
    Compare competitors

    Deep Genomics News and Updates

    April 10, 2018

    BRIEF-Wave Life Sciences And Deep Genomics Form Collaboration To Discover Therapies For Genetic Neuromuscular Disorders

    * WAVE LIFE SCIENCES AND DEEP GENOMICS FORM COLLABORATION TO DISCOVER NOVEL THERAPIES FOR GENETIC NEUROMUSCULAR DISORDERS
    September 26, 2017

    Deep Genomics lands $13 mln in follow-on round led by Khosla

    Deep Genomics, a Toronto genetic medicine startup, has raised $13 million in follow-on financing. Khosla Ventures led the round and was joined by True Ventures, which led the company’s $5 million seed financing in 2015. Spun out of the University of Toronto in 2014, Deep Genomics is building a biolo…
    Report incorrect company information
    Download PDF